RB1 and cancer: Comprehensive next‐generation sequencing (NGS) and Sanger sequencing did not reveal any pathogenic variants in RB1 or other cancer predisposition genes, suggesting that the sequential cancers were likely driven by treatment‐related mutagenesis rather than inherited genetic factors.